TrialLeukemia2022

Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis.

Paul J Bröckelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.